Low fecal rotavirus vaccine virus shedding is significantly associated with non-secretor histo-blood group antigen phenotype among infants in northern Pretoria, South Africa

Vaccine. 2020 Dec 14;38(52):8260-8263. doi: 10.1016/j.vaccine.2020.11.025. Epub 2020 Nov 16.

Abstract

Histo-blood group antigens are recognized by rotaviruses in a P- genotype dependent manner and their frequency in a population can influence fecal virus shedding. This study investigated the rate of fecal shedding of Rotarix vaccine and its association with HBGA phenotype distribution in South Africa. Stool and saliva specimens were collected from 150 infants attending immunization on the day of both first and second doses and 7 days later. Virus shedding was detected by real-time qPCR while HBGA phenotypes in saliva were determined by enzyme linked immunosorbent assay. Vaccine virus shedding was higher (23.6%) after the first dose than the second dose (4.7%). About 77% of virus-shedding infants were secretors (OR = 129; 95% CI, 6.088 - 2733), compared with none of non-virus shedding infants. Non-secretor status was significantly associated with low vaccine virus shedding while the likelihood of shedding was significantly higher in secretors.

Keywords: Fecal shedding; HBGA; Rotarix vaccine; Rotavirus; South Africa.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Group Antigens*
  • Feces
  • Humans
  • Infant
  • Phenotype
  • Rotavirus Infections* / prevention & control
  • Rotavirus Vaccines*
  • Rotavirus* / genetics
  • South Africa
  • Virus Shedding

Substances

  • Blood Group Antigens
  • Rotavirus Vaccines